Home » Dipexium Announces Top-line Data from OneStep Phase III Trials
Dipexium Announces Top-line Data from OneStep Phase III Trials
Dipexium Pharmaceuticals announced that the OneStep-1 and OneStep-2 Phase 3 clinical trials of Locilex (pexiganan cream 0.8%) in patients with mild infections of diabetic foot ulcers (Mild DFI) did not meet the primary clinical endpoint of superiority versus a cream vehicle plus standardized wound care.
The clinical trials conducted simultaneously enrolled a total of 389 patients at 59 separate centers in the U.S.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May